Evidence map›Paper›PMID 28714086›Full record

ArticleThe Journal of physiology2017

N-glycan content modulates kainate receptor functional properties.

Claire G Vernon, Bryan A Copits, Jacob R Stolz, Yomayra F Guzmán, Geoffrey T Swanson

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Sialylation in the nervous system: Functions and mechanisms.The Journal of biological chemistry · 2026
    Review
  3. The Neuronal Golgi Network and Its Acolytes.Sub-cellular biochemistry · 2026
    Review
  4. Article
  5. Article
  6. Dynamic glycosylation remodeling in neurological disorders.Frontiers in molecular neuroscience · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Architecture and Dynamics of the Neuronal Secretory Network.Annual review of cell and developmental biology · 2019
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Claire G VernonNorthwestern University, Feinberg School of Medicine, Dept. of Pharmacology, Chicago, Illinois, 60611.
Bryan A CopitsNorthwestern University, Feinberg School of Medicine, Dept. of Pharmacology, Chicago, Illinois, 60611.
Jacob R StolzNorthwestern University, Feinberg School of Medicine, Dept. of Pharmacology, Chicago, Illinois, 60611.
Yomayra F GuzmánNorthwestern University, Feinberg School of Medicine, Dept. of Pharmacology, Chicago, Illinois, 60611.
Geoffrey T SwansonNorthwestern University, Feinberg School of Medicine, Dept. of Pharmacology, Chicago, Illinois, 60611.
Northwestern University · US

Funding

Galectin Modulation of Glutamate Receptors and Neuronal FunctionR01NS080598 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SWANSON, GEOFFREY T · 2013 to 2017
$1.9M
Role of 4.1 proteins in kainate receptor localization and functionR01NS071952 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SWANSON, GEOFFREY T · 2010 to 2013
$1.3M
NINDS NIH HHS R01 NS071952NINDS NIH HHS R01 NS080598
6 · The paper itself

Abstract

key pointsIonotropic glutamate receptor (iGluR) subunits are N-glycosylated at 4-12 sites, and Golgi processing produces mature receptors that contain high-mannose, hybrid and complex oligosaccharides. N-glycosylation is crucial for receptor biogenesis, influences receptor trafficking and provides a binding site for carbohydrate binding proteins. Glycan moieties are large, polar and occasionally charged, and they are attached at sites along iGluRs that position them for involvement in the structural changes underlying gating. Altering glycan content on kainate receptors (KARs), a subfamily of iGluRs, changes functional properties of the receptor, such as desensitization, recovery from desensitization and deactivation. We report the first observation that the charged trisaccharide HNK-1 is conjugated to native KARs, and we find that it substantially alters recombinant KAR functional properties. Our results show that the molecular composition of N-glycans can influence KAR biophysical properties, revealing a potential mechanism for fine-tuning the function of these receptors. ABSTRACT: Ionotropic glutamate receptors (iGluRs) are tetrameric proteins with between four and 12 consensus sites for N-glycosylation on each subunit, which potentially allows for a high degree of structural diversity conferred by this post-translational modification. N-glycosylation is required for proper folding of iGluRs in mammalian cells, although the impact of oligosaccharides on the function of successfully folded receptors is less clear. Glycan moieties are large, polar, occasionally charged and mediate many protein-protein interactions throughout the nervous system. Additionally, they are attached at sites along iGluR subunits that position them for involvement in the structural changes underlying gating. In the present study, we show that altering glycan content on kainate receptors (KARs) changes the functional properties of the receptors in a manner dependent on the identity of both the modified sugars and the subunit composition of the receptor to which they are attached. We also report that native KARs carry the complex capping oligosaccharide human natural killer-1. Glycosylation patterns probably differ between cell types, across development or with pathologies, and thus our findings reveal a potential mechanism for context-specific fine-tuning of KAR function through diversity in glycan structure.

Indexed as

Alkaloidsalpha-MannosidaseAnimalsFemaleGlycosylationHEK293 CellsHumansKainic Acid ReceptorsMaleMice, Inbred C57BLMice, KnockoutPolysaccharidesSwainsonineAlkaloidsalpha-MannosidaseKainic Acid ReceptorskifunensinePolysaccharidesSwainsoninedeactivationdesensitizationHNK-1

Identifiers

PMID28714086
PMCPMC5577532
OpenAlexW2735564245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.